Failure of cetirizine and fexofenadine to prevent motion sickness

Annals of Pharmacotherapy

Volumn 37, Issue 2, 2003, Pages 173-177

  Cheung, Bob S ^a   Heskin, Raquel ^b   Hofer, Kevin D ^b   Rivera Miranda, Giselle C ^b   Paquette Lamontagne, Nicolas ^b  

^a DEFENCE RESEARCH AND DEVELOPMENT CANADA   (Canada)

^b NONE

Author keywords

Emesis; Motion sickness; Nausea; Second generation antihistamines

Indexed keywords

ANTIHISTAMINIC AGENT; ASTEMIZOLE; CETIRIZINE; FEXOFENADINE; HYDROXYZINE; PLACEBO;

ADULT; ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE PREDISPOSITION; DISEASE SEVERITY; DRUG EFFICACY; DRUG MECHANISM; FEMALE; HUMAN; MALE; MOTION SICKNESS; NORMAL HUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEDATION; SIDE EFFECT; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 0037312608     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1177/106002800303700201     Document Type: Article

References (24)

1. Brand JJ, Perry WLM. Drugs used in motion sickness. Pharmacol Rev 1966;18:895-924.
2. de Abajo FJ, Rodriguez LA. Risk of ventricular arrhythmias associated with nonsedating antihistamine drugs. Br J Clin Pharmcol 1999;47:307-13.
3. Kohl RL, Calkins DS, Robinson RE. Control of nausea and autonomic dysfunction with terfenadine, a peripherally acting antihistamine. Aviat Space Environ Med 1991;62:392-6.
4. 1-antihistamine, cetirizine. Aviat Space Environ Med 1998;69:166-71.
5. Barnes CL, McKenzie CA, Webster KD, Poinsett-Holmes K. Cetirizine: a new, nonsedating antihistamine. Ann Pharmacother 1993;27:464-70.
6. Erez S, Schifrin BS, Dirim O. Double-blind evaluation of hydroxyzine as an antiemetic in pregnancy. J Reprod Med 1971;7:35-7.
7. Marks E, Swiecicki W. [Prevention and treatment of motion sickness.] Polish. Wiad Lek 1974;27:37-42.
8. Einarson A, Levichek Z, Einarson TR, Koren G. The antiemetic effect of cetirizine during pregnancy (letter). Ann Pharmacother 2000;34:1486-7.
9. Golaszewski TM, Frigo P, Mark HE, Rattay F, Schaller A. Treatment of hyperemesis gravidarum by electrical stimulation of the vestibular system. J Psychosom Obstet Gynaecol 1997;18:244-6.
10. Markham A, Wagstaff AJ. Fexofenadine. Drugs 1998;55:269-74.
11. Guedry FE, Montague EK. Quantitative evaluation of the vestibular coriolis reaction. Aerospace Med 1961;32:487-500.
12. Miller EF 2nd, Graybiel A. A provocative test for grading susceptibility to motion sickness yielding a single numerical score. Acta Otolaryngol Suppl 1970;274:1-20.
13. Kohl RL. Failure of metoclopramide to control emesis or nausea due to stressful angular or linear acceleration. Aviat Space Environ Med 1987;58:125-31.
14. Miller EF 2nd, Graybiel A. Motion sickness produced by head movement as a function of rotational velocity. Pensacola, FL: Naval Aerospace Medical Institute, 1970:NAMI-1101.
15. Graybiel A, Wood CD, Miller EF, Cramer DB. Diagnostic criteria for grading the severity of acute motion sickness. Aerospace Med 1968;39:453-5.
16. Golding JF, Kerguelen M. A comparison of the nauseogenic potential of low frequency vertical versus horizontal linear oscillation. Aviat Space Environ Med 1992;63:491-7.
17. Spielberger CD. Manual for the state-trait anxiety inventory (form Y). Palo Alto, CA: Consulting Psychologists Press, 1983.
18. Miller AD. Wilson VJ. Vomiting center re-analyzed: an electrical stimulation study. Brain Res 1983;270:154-8.
19. 1 receptors in the rat brain: an autoradiographic study. Neuroscience 1981;6:15-38.
20. Wamsley JK, Palacios JM. Histaminergic receptors. In: Bjorklund A, Hokfelt T, Kuhar MJ, eds. Handbook of chemical neuroanatomy. Vol 3. Classical transmitters and transmitter receptors in the CNS, Part II. Elsevier, Amsterdam: 1984:386-406.
21. Wood CD, Graybiel A. Evaluation of sixteen anti-motion sickness drugs under controlled laboratory conditions. Aerospace Med 1968;39:1341-4.
22. Guedry FE. Motion sickness and its relation to some forms of spatial orientation: mechanisms and theory. In: AGARD lecture series 175. Motion sickness in aerospace operations and prophylaxis. October 7-8, 1991, Toronto, Canada.
23. Kohl RL, Homick JL, Cintron N, Calkins DS. Lack of effects of astemizole on vestibular ocular reflex, motion sickness, and cognitive performance in man. Aviat Space Environ Med 1987;58:1171-4.
24. Jackson RT, Turner JS. Astemizole: its use in the treatment of patients with chronic vertigo. Arch Otolaryngol Head Neck Surg 1987;113:536-42.